Clinical Trial Update: Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects [Phase 3]

View source ↗

Summary

Long-term extension of a Phase 3 study investigating ALZ-801 in APOE4/4 carriers with early Alzheimer's disease; the trial is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ALZ-801

Snippet

Sponsor: Alzheon Inc. | Conditions: Early Alzheimer's Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING